Cme (CME) Cost of Revenue (2009 - 2026)

Cme (CME) has reported Cost of Revenue for 18 consecutive years, with $59.9 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cost of Revenue rose 12.59% year-over-year to $59.9 million; the TTM figure through Jun 2026 stood at $253.4 million (down 2.61% YoY), while the FY2025 annual figure was $248.5 million, down 7.14% from the prior year.
• Cost of Revenue climbed to $59.9 million in Q2 2026 per CME's latest filing, from $52.5 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $101.9 million in Q4 2023 and bottomed at $43.9 million in Q3 2022.
• Historically, Cost of Revenue has averaged $63.7 million across 5 years, with a median of $57.0 million in 2023.
• Annual changes were most pronounced in 2023 — Cost of Revenue gained 28.7% — and 2025, when it retreated 11.56%.
• Cme's Cost of Revenue stood at $95.0 million in 2022, then increased by 7.26% to $101.9 million in 2023, then fell by 11.29% to $90.4 million in 2024, then retreated by 4.98% to $85.9 million in 2025, then sank by 30.27% to $59.9 million in 2026.
• Business Quant data shows CME's Cost of Revenue at $59.9 million in Q2 2026, $52.5 million in Q1 2026, and $85.9 million in Q4 2025.